North America Human Growth Hormone Market Size & Outlook
North America human growth hormone market, 2018-2030 (US$M)
Related Markets
North America human growth hormone market highlights
- The North America human growth hormone market generated a revenue of USD 2,665.8 million in 2023.
- The market is expected to grow at a CAGR of 12.1% from 2024 to 2030.
- In terms of segment, growth hormone deficiency was the largest revenue generating application in 2023.
- Growth Hormone Deficiency is the most lucrative application segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 2,665.8 million |
| Market revenue in 2030 | USD 5,918.9 million |
| Growth rate | 12.1% (CAGR from 2023 to 2030) |
| Largest segment | Growth hormone deficiency |
| Fastest growing segment | Growth Hormone Deficiency |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, Small for Gestational Age, Other Applications, Growth Hormone Deficiency |
| Key market players worldwide | Novo Nordisk A/S ADR, Eli Lilly and Co, Pfizer Inc, Sandoz Group AG ADR, Roche, Ferring, Ipsen SA, Teva Pharmaceutical Industries Ltd |
Other key industry trends
- In terms of revenue, North America region accounted for 42.2% of the global human growth hormone market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 2,726.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Human Growth Hormone Market Scope
Human Growth Hormone Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America human growth hormone market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to human growth hormone market will help companies and investors design strategic landscapes.
Growth hormone deficiency was the largest segment with a revenue share of 48.67% in 2023. Horizon Databook has segmented the North America human growth hormone market based on turner syndrome, idiopathic short stature, prader-willi syndrome, small for gestational age, other applications, growth hormone deficiency covering the revenue growth of each sub-segment from 2018 to 2030.
- North America Human Growth Hormone Application Outlook (Revenue, USD Million, 2018-2030)
- Turner Syndrome
- Idiopathic Short Stature
- Prader-Willi Syndrome
- Small for Gestational Age
- Other Applications
- Growth Hormone Deficiency
- Adult Growth Hormone Deficiency
- Pediatric Growth Hormone Deficiency
- North America Human Growth Hormone Distribution Channel Outlook (Revenue, USD Million, 2018-2030)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Specialty Pharmacy
- North America Human Growth Hormone Product Outlook (Revenue, USD Million, 2018-2030)
- Long Acting
- Other Products
Reasons to subscribe to North America human growth hormone market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America human growth hormone market databook
-
Our clientele includes a mix of human growth hormone market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America human growth hormone market , including forecasts for subscribers. This continent databook contains high-level insights into North America human growth hormone market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America human growth hormone market size, by country, 2018-2030 (US$M)
North America Human Growth Hormone Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
